Tag: sensorineural hearing loss

All

Latest

Frequency Therapeutics to Provide Conference Sponsorship

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, announced that it will provide student conference sponsorship for a second year to the Future of Hearing Healthcare Conference, which will allow up to 75 audiology graduate students to attend the event at no cost.

All

Latest

Losartan May Help Patients with Vestibular Schwannomas

New research led by investigators at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

All

Latest

Study Shows Hearing Improvement with Esteem Implant

Envoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced an independent study that was published online in 'The Journal of Laryngology & Otology.' The study found that the fully implanted Esteem osseointegrated active middle ear implant (AMEI) showed “statistically significant improvements in post-operative hearing results,” according to Envoy.

Managing People with Sensorineural and Conductive Unilateral Hearing Loss and Single-Sided Deafness

CROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.

Read More
Loading